Loading
Life sciences · Journal article
Jornal Brasileiro De Nefrologia · January 1, 2027
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Over recent decades, the prevalence of chronic kidney disease (CKD) has risen markedly. In the terminal stage of the disease, renal replacement therapy (RRT) is traditionally recommended as the standard therapeutic approach. However, in older individuals with a high burden of comorbidities or substantial functional impairment, the benefits of RRT in terms of survival prolongation or improvement in quality of life become uncertain. In this context, comprehensive conservative kidney management (CKM) has emerged as a clinical alternative that is centered on the patient's needs, values, and preferences. CKM entails an active, nondialytic management strategy for CKD that incorporates palliative care principles, with emphasis on kidney supportive care, slowing disease progression, and symptom control. This article discusses the main symptoms experienced by patients with advanced CKD managed conservatively and provides practical recommendations for their clinical management.